-
Adair LB 2nd, Ledermann EJ, 2020: Chest CT findings of early and progressive phase COVID-19 infection from a US patient[J]. Radiol Case Rep, 15, 819-824. doi: 10.1016/j.radcr.2020.04.031
-
Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, Jeong SJ, Kim JH, Ku NS, Yeom JS, Roh J, Ahn MY, Chin BS, Kim YS, Lee H, Yong D, Kim HO, Kim S, Choi JY, 2020: Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea[J]. J Korean Med Sci, 35, e149-. doi: 10.3346/jkms.2020.35.e149
-
Al-Gethamy M, Corman VM, Hussain R, Al-Tawfiq JA, Drosten C, Memish ZA, 2015: A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker[J]. Clin Infect Dis, 60, 973-974. doi: 10.1093/cid/ciu1135
-
Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G, 2005: Use of convalescent plasma therapy in SARS patients in Hong Kong[J]. Eur J Clin Microbiol Infect Dis, 24, 44-46. doi: 10.1007/s10096-004-1271-9
-
Chinese National Health Commission (2020) New coronavirus pneumonia prevention and control program. Accessed on http://www.nhc.gov.cn/yzygj/s7653pd/202003/056b2ce9e13142e6a70ec08ef970f1e8.shtml
-
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C, 2020: Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR[J]. Euro Surveill, 25, 2000045-.
-
Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X, 2020: Effectiveness of convalescent plasma therapy in severe COVID-19 patients[J]. Proc Natl Acad Sci U S A, 117, 9490-9496. doi: 10.1073/pnas.2004168117
-
Hu X, Xing Y, Jia J, Ni W, Liang J, Zhao D, Song X, Gao R, Jiang F, 2020: Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19[J]. Sci Total Environ, 728, 138812-. doi: 10.1016/j.scitotenv.2020.138812
-
Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW, Liu R, Watt CL, Chan WM, Lai KY, Koo CK, Buckley T, Chow FL, Wong KK, Chan HS, Ching CK, Tang BS, Lau CC, Li IW, Liu SH, Chan KH, Lin CK, Yuen KY, 2011: Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection[J]. Clin Infect Dis, 52, 447-456. doi: 10.1093/cid/ciq106
-
Ivers LC, Walton DA, 2020: Novel coronavirus disease (COVID-19): global health equity in pandemic response[J]. Am J Trop Med Hyg, 102, 1149-1150. doi: 10.4269/ajtmh.20-0260
-
Kirby T, 2020: South America prepares for the impact of COVID-19[J]. Lancet Respir Med, 8, 551-552. doi: 10.1016/S2213-2600(20)30218-6
-
Kraaij-Dirkzwager M, Timen A, Dirksen K, Gelinck L, Leyten E, Groeneveld P, Jansen C, Jonges M, Raj S, Thurkow I, van Gageldonk-Lafeber R, van der Eijk A, Koopmans M, MERS-CoV Outbreak Investigation Team of the Netherlands (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveill 19: 20817
-
Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, Larson L, Varkey JB, Mehta AK, Lyon GM 3rd, Friedman-Moraco RJ, Marconi VC, Hill CE, Sullivan JN, Johnson DW, Lisco SJ, Mulligan MJ, Uyeki TM, McElroy AK, Sealy T, Campbell S, Spiropoulou C, Ströher U, Crozier I, Sacra R, Connor MJ Jr, Sueblinvong V, Franch HA, Smith PW, Ribner BS; Nebraska Biocontainment Unit and The Emory Serious Communicable Diseases Unit (2015) The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States. Clin Infect Dis 61: 496-502
-
Li N, Wang X, Lv T, 2020: Prolonged SARS-CoV-2 RNA shedding: not a rare phenomenon[J]. J Med Virol, , -. doi: 10.1002/jmv.25952
-
Little P, Read RC, Amlôt R, Chadborn T, Rice C, Bostock J, Yardley L, 2020: Reducing risks from coronavirus transmission in the home-the role of viral load[J]. BMJ, 369, m1728-.
-
Liu WD, Chang SY, Wang JT, Tsai MJ, Hung CC, Hsu CL, Chang SC, 2020: Prolonged virus shedding even after seroconversion in a patient with COVID-19[J]. J Infect, 81, 318-356.
-
Luke TC, Kilbane EM, Jackson JL, Hoffman SL, 2006: Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment[J]. Ann Intern Med, 145, 599-609. doi: 10.7326/0003-4819-145-8-200610170-00139
-
Saglietto A, D'Ascenzo F, Zoccai GB, De Ferrari GM, 2020: COVID-19 in Europe: the Italian lesson[J]. Lancet, 395, 1110-1111. doi: 10.1016/S0140-6736(20)30690-5
-
Sahr F, Ansumana R, Massaquoi TA, Idriss BR, Sesay FR, Lamin JM, Baker S, Nicol S, Conton B, Johnson W, Abiri OT, Kargbo O, Kamara P, Goba A, Russell JB, Gevao SM, 2017: Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone[J]. J Infect, 74, 302-309. doi: 10.1016/j.jinf.2016.11.009
-
Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L, 2020: Treatment of 5 critically ill patients with COVID-19 with convalescent plasma[J]. JAMA, 323, 1582-1589. doi: 10.1001/jama.2020.4783
-
Shi D, Wu W, Wang Q, Xu K, Xie J, Wu J, Lv L, Sheng J, Guo J, Wang K, Fang D, Li Y, Li L, 2020: Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study[J]. J Infect Dis, 222, 910-918. doi: 10.1093/infdis/jiaa388
-
Spanakis N, Tsiodras S, Haagmans BL, Raj VS, Pontikis K, Koutsoukou A, Koulouris NG, Osterhaus AD, Koopmans MP, Tsakris A, 2014: Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen[J]. Int J Antimicrob Agents, 44, 528-532. doi: 10.1016/j.ijantimicag.2014.07.026
-
Walsh KA, Jordan K, Clyne B, Rohde D, Drummond L, Byrne P, Ahern S, Carty PG, O'Brien KK, O'Murchu E, O'Neill M, Smith SM, Ryan M, Harrington P, 2020: SARS-CoV-2 detection, viral load and infectivity over the course of an infection: SARS-CoV-2 detection, viral load and infectivity[J]. J Infect, 81, 357-371. doi: 10.1016/j.jinf.2020.06.067
-
Wan R, Mao ZQ, He LY, Hu YC, Chen W, 2020: Evidence from two cases of asymptomatic infection with SARS-CoV-2: are 14 days of isolation sufficient[J]. Int J Infect Dis, 95, 174-175. doi: 10.1016/j.ijid.2020.03.041
-
Wang B, Wang L, Kong X, Geng J, Xiao D, Ma C, Jiang XM, Wang PH, 2020: Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients[J]. J Med Virol, , -. doi: 10.1002/jmv.25946
-
Wang Z, Yang B, Li Q, Wen L, Zhang R, 2020: Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China[J]. Clin Infect Dis, 71, 769-777. doi: 10.1093/cid/ciaa272
-
Yan D, Liu XY, Zhu YN, Huang L, Dan BT, Zhang GJ, Gao YH, 2020: Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection[J]. Eur Respir J, 56, 2000799-. doi: 10.1183/13993003.00799-2020
-
Yang JR, Deng DT, Wu N, Yang B, Li HJ, Pan XB, 2020: Persistent viral RNA positivity during the recovery period of a patient with SARS-CoV-2 infection[J]. J Med Virol, , -. doi: 10.1002/jmv.25940
-
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y, 2020a: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study[J]. Lancet Respir Med, 8, 475-481. doi: 10.1016/S2213-2600(20)30079-5
-
Yang X, Yang Q, Wang Y, Wu Y, Xu J, Yu Y, Shang Y, 2020b: Thrombocytopenia and its association with mortality in patients with COVID-19[J]. J Thromb Haemost, 18, 1469-1472. doi: 10.1111/jth.14848
-
Zhang YC, Han S, Wang X, Shi X, Li Y, Yan J, Chen Y, Gu B, 2020: Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients[J]. Emerg Microbes Infect, 9, 833-836. doi: 10.1080/22221751.2020.1756699
-
Zeng QL, Yu ZJ, Gou JJ, Li GM, Ma SH, Zhang GF, Xu JH, Lin WB, Cui GL, Zhang MM, Li C, Wang ZS, Zhang ZH, Liu ZS, 2020: Effect of convalescent plasma therapy on viral shedding and survival in COVID-19 patients[J]. J Infect Dis, 222, 38-43. doi: 10.1093/infdis/jiaa228
-
Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L, Chen Q, Zhang L, Zhong Q, Zhang X, Zou Y, Zhang S, 2020: Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection[J]. Chest, 158, e9-e13. doi: 10.1016/j.chest.2020.03.039
-
Zhou B, Zhong N, Guan Y, 2007: Treatment with convalescent plasma for influenza A (H5N1) infection[J]. N Engl J Med, 357, 1450-1451. doi: 10.1056/NEJMc070359
-
Zhou B, She J, Wang Y, Ma X, 2020: The duration of viral shedding of discharged patients with severe COVID-19[J]. Clin Infect Dis, , -. doi: 10.1093/cid/ciaa451
-
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, 2020: China Novel Coronavirus Investigating and Research Team (2020) China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 382, 727-733. doi: 10.1056/NEJMoa2001017
-
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J, 2020: SARS-CoV-2 viral load in upper respiratory specimens of infected patients[J]. N Engl J Med, 382, 1177-1179. doi: 10.1056/NEJMc2001737